Clinical Trials Directory

Trials / Completed

CompletedNCT00136266

Adherence With Iron Sprinkles Among High-Risk Infants

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
128 (actual)
Sponsor
Centers for Disease Control and Prevention · Federal
Sex
All
Age
5 Months – 7 Months
Healthy volunteers
Accepted

Summary

Compared with iron drops, iron sprinkles supplied for 3 months to high-risk children beginning at age 5-7 months will increase adherence and reduce the rates of anemia and iron deficiency.

Detailed description

Iron deficiency is the most common known nutrient deficiency and cause of anemia in childhood. It is associated with numerous adverse health effects, particularly delayed mental and motor development, that may be irreversible. Despite advances of iron nutrition, the prevalence of iron deficiency remains high among low-income infants and toddlers. Previous studies suggest adherence with iron containing drops is low. Adherence to iron sprinkles among children as tested in studies in less developed countries appears high. Comparison: Children randomized to ferrous sulfate drops will be compared with children randomized to ferrous fumarate sprinkles.

Conditions

Interventions

TypeNameDescription
DRUGFerrous sulphate drops with vitamins A, D, and C
DRUGFerrous fumarate sprinkles with vitamins and minerals

Timeline

Start date
2005-03-01
Primary completion
2005-12-01
Completion
2005-12-01
First posted
2005-08-29
Last updated
2016-02-03

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00136266. Inclusion in this directory is not an endorsement.